Featured Research

from universities, journals, and other organizations

Drugging the undruggable: Advances toward next generation of disease fighters

Date:
August 23, 2010
Source:
American Chemical Society
Summary:
After decades of dreaming the drug developer's impossible dream, scientists finally are reporting progress in making drugs that target the "untouchables" among the body's key players in health and disease. They are the hundreds of thousands of proteins that many scientists considered to be "undruggable," meaning that previous efforts to develop a drug against them had failed.

After decades of dreaming the drug developer's impossible dream, scientists finally are reporting progress in making drugs that target the "untouchables" among the body's key players in health and disease. They are the hundreds of thousands of proteins that many scientists considered to be "undruggable," meaning that previous efforts to develop a drug against them had failed.

Scientists described advances toward these drugs Aug. 23 during a special symposium, "Drugging the Undruggable," at the 240th National Meeting of the American Chemical Society. The advances could lead to a new generation of medicines for treating cancer, diabetes, and other major diseases, they said.

In one advance, scientists reported on a new family of potential drugs that are capable of blocking a key protein that's involved in the development of cancer. Called "stapled peptides," the substances get their name from chemical "braces" that hold the peptides, or protein fragments, in a compact shape that gives them high stability in comparison to their unfolded versions. The three-dimensional shape is critical for the peptide to function normally and help orchestrate body processes. The chemical stapling allows them to resist destruction by enzymes, easily penetrate cells, and bind to biochemical machinery within cells.

Their report indicated that the stapled peptides prevented the growth of cancer cells in a group of test animals, a key advance toward the start of clinical trials in a group of cancer patients.

"Stapled peptides represent an entirely new class of potential drugs," said study leader Gregory Verdine, Ph.D., who has been studying the molecules for the past decade and helped pioneer their development. "They herald a new era in the drug-discovery world."

There are hundreds of thousands of proteins in the human body, many of them with links to human disease. However, only a tiny fraction -- about 20 percent -- of these proteins is considered "druggable." Thanks to a new generation of drug discovery technologies, that tiny fraction is now on the rise.

"The entire pharmaceutical industry has been working on drug-design platforms that focus on this little sliver of human drug targets and this limits the drug arsenal available to doctors," said Verdine, a chemical biologist at Harvard University in Cambridge, Mass. "What's required is an entirely new class of drugs that overcome the shortcomings of drugs of the past."

In addition to "stapled peptides," scientists described new insights into how proteins interact with other proteins, the use of small molecules to target and treat cancer, and related topics. The presenters included scientists from government, industry, and academia.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Drugging the undruggable: Advances toward next generation of disease fighters." ScienceDaily. ScienceDaily, 23 August 2010. <www.sciencedaily.com/releases/2010/08/100823162314.htm>.
American Chemical Society. (2010, August 23). Drugging the undruggable: Advances toward next generation of disease fighters. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2010/08/100823162314.htm
American Chemical Society. "Drugging the undruggable: Advances toward next generation of disease fighters." ScienceDaily. www.sciencedaily.com/releases/2010/08/100823162314.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins